LAVA Therapeutics NV
LVTX1.415USD
-0.005-0.35%
시장 운영 시간 （ET）시세는 15분 지연됩니다
37.22M시가총액
손실P/E TTM
자세한 내용은 LAVA Therapeutics NV 회사
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
회사 정보
종목 코드 LVTX
회사 이름LAVA Therapeutics NV
상장일Mar 25, 2021
CEOMr. Stephen A. Hurly
직원 수34
유형Ordinary Share
회계 연도 종료Mar 25
주소Yalelaan 60
도시UTRECHT
증권 거래소NASDAQ Global Select Consolidated
국가Netherlands
우편 번호3584 CM
전화31630003035
웹사이트https://www.lavatherapeutics.com/
종목 코드 LVTX
상장일Mar 25, 2021
CEOMr. Stephen A. Hurly
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Hans Van Der Vliet, M.D., Ph.D.
Mr. Hans Van Der Vliet, M.D., Ph.D.
Chief Scientific Officer
Chief Scientific Officer
77.35K
--
Dr. Kapil Dhingra, M.D.
Dr. Kapil Dhingra, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
30.00K
--
Ms. Karen J. Wilson
Ms. Karen J. Wilson
Non-Executive Independent Director
Non-Executive Independent Director
10.00K
--
Ms. Amy Garabedian
Ms. Amy Garabedian
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
8.85K
--
Ms. Nanna L. Lueneborg, Ph.D.
Ms. Nanna L. Lueneborg, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Dr. Guido Magni, M.D., Ph.D.
Dr. Guido Magni, M.D., Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Stephen A. Hurly
Mr. Stephen A. Hurly
President, Chief Executive Officer, Management Director
President, Chief Executive Officer, Management Director
--
--
Mr. Joel Jean-Mairet, Ph.D.
Mr. Joel Jean-Mairet, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Benjamin Winograd, M.D., Ph.D.
Mr. Benjamin Winograd, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Paul W.H.I. Parren
Dr. Paul W.H.I. Parren
Executive Vice President Head of Research and Development
Executive Vice President Head of Research and Development
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Hans Van Der Vliet, M.D., Ph.D.
Mr. Hans Van Der Vliet, M.D., Ph.D.
Chief Scientific Officer
Chief Scientific Officer
77.35K
--
Dr. Kapil Dhingra, M.D.
Dr. Kapil Dhingra, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
30.00K
--
Ms. Karen J. Wilson
Ms. Karen J. Wilson
Non-Executive Independent Director
Non-Executive Independent Director
10.00K
--
Ms. Amy Garabedian
Ms. Amy Garabedian
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
8.85K
--
Ms. Nanna L. Lueneborg, Ph.D.
Ms. Nanna L. Lueneborg, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Dr. Guido Magni, M.D., Ph.D.
Dr. Guido Magni, M.D., Ph.D.
Non-Executive Director
Non-Executive Director
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Wed, Jun 4
마지막 업데이트: Wed, Jun 4
주주
주주 유형
주주
주주
비율
Cooperatieve Gilde Healthcare IV UA
20.61%
Versant Ventures
17.44%
Redmile Group, LLC
7.89%
BML Capital Management LLC
7.45%
Sanofi SA
7.30%
Other
39.31%
주주
주주
비율
Cooperatieve Gilde Healthcare IV UA
20.61%
Versant Ventures
17.44%
Redmile Group, LLC
7.89%
BML Capital Management LLC
7.45%
Sanofi SA
7.30%
Other
39.31%
주주 유형
주주
비율
Corporation
32.27%
Venture Capital
17.53%
Investment Advisor
10.83%
Investment Advisor/Hedge Fund
7.95%
Hedge Fund
0.42%
Individual Investor
0.42%
Research Firm
0.22%
Other
30.35%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
48
18.32M
69.65%
-2.73M
2025Q1
59
22.25M
84.60%
-1.27M
2024Q4
61
18.80M
71.50%
-11.80K
2024Q3
56
15.93M
60.60%
-3.34M
2024Q2
58
16.07M
61.13%
-4.19M
2024Q1
58
16.06M
61.10%
-4.38M
2023Q4
51
18.10M
68.85%
+283.15K
2023Q3
52
18.00M
68.48%
-418.56K
2023Q2
55
18.03M
68.58%
-1.16M
2023Q1
60
19.21M
73.06%
-886.64K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Cooperatieve Gilde Healthcare IV UA
5.42M
20.61%
--
--
Mar 31, 2025
Versant Ventures
4.59M
17.44%
--
--
Mar 31, 2025
Redmile Group, LLC
2.07M
7.89%
--
--
Mar 31, 2025
BML Capital Management LLC
1.96M
7.45%
+2.50K
+0.13%
Mar 31, 2025
Sanofi SA
1.92M
7.3%
+1.92M
--
Dec 31, 2024
Merck & Co Inc
1.15M
4.37%
--
--
Mar 31, 2025
Bruce & Company, Inc.
521.87K
1.98%
-250.00K
-32.39%
Mar 31, 2025
Zenito Oy
156.83K
0.6%
--
--
Mar 31, 2025
Pathway Financial Advisors, LLC
102.50K
0.39%
--
--
Mar 31, 2025
Powell (Fred M)
65.00K
0.25%
-7.56K
-10.42%
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
이름
비율
AltShares Event-Driven ETF
0%
AltShares Event-Driven ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
